
NuVasive NUVA
Quartalsbericht 2023-Q2
hinzugefügt 02.08.2023
NuVasive Langfristige Verbindlichkeiten 2011-2026 | NUVA
Langfristige Verbindlichkeiten Jährlich NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 763 M | 694 M | 679 M | 628 M | 488 M | 480 M | 458 M | 462 M | 411 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 763 M | 411 M | 563 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
184 M | $ 190.07 | 2.73 % | $ 14.2 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 12.66 | 0.64 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.49 | -2.79 % | $ 131 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 64.23 | 1.28 % | $ 95.1 B | ||
|
Electromed
ELMD
|
8.87 K | $ 26.06 | 2.64 % | $ 220 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.66 | 8.2 % | $ 41.1 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.79 | 12.29 % | $ 334 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.75 | 1.33 % | $ 393 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
LENSAR
LNSR
|
3.44 M | $ 5.93 | 2.24 % | $ 70.9 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 95.25 | 2.7 % | $ 12.9 B | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.12 | 2.91 % | $ 1.29 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Inogen
INGN
|
52.5 M | $ 6.82 | 3.49 % | $ 181 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.06 | 1.92 % | $ 18 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.86 | 0.28 % | $ 389 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 57.59 | 2.02 % | $ 1.69 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 39.08 | 3.09 % | $ 1.21 B | ||
|
LivaNova PLC
LIVN
|
516 M | $ 67.12 | 3.25 % | $ 3.66 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 90.2 | 2.07 % | $ 3.13 B | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.8 | 0.21 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 80.99 | 2.45 % | $ 47.4 B | ||
|
Sintx Technologies
SINT
|
1.76 M | $ 2.7 | 0.75 % | $ 7.49 M | ||
|
Penumbra
PEN
|
89.2 M | $ 332.13 | 0.2 % | $ 12.9 B | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M |